\n\u201eRom\u00e2nia are o tradi\u0163ie \u00eendelungat\u0103 \u00een industria farmaceutic\u0103, iar contribu\u0163ia pe care fabricile de medicamente din Rom\u00e2nia, indiferent de capital, o au la dezvoltarea economic\u0103 este esen\u0163ial\u0103 pentru evolu\u0163ia noastr\u0103 c\u0103 stat european modern\u201d a declarat Drago\u015f Damian, director executiv PRIMER. <\/p>\n
\n\u201eSectorul manufacturierii produselor farmaceutice este strategic, pl\u0103te\u015fte taxe \u015fi impozite \u00een Rom\u00e2nia, a creat mii de locuri de munc\u0103 pentru personal de \u00eenalta calificare \u015fi asigura medicamente esen\u0163iale pentru rom\u00e2ni, \u00een ciuda unui mediu concuren\u0163ial care \u00eei este potrivnic \u015fi \u00een care nu g\u0103se\u015fte niciun sprijin din partea autorit\u0103\u0163ilor. Medicamentul \u201cMade \u00een Rom\u00e2nia\u201d este respectat \u00een peste 100 de \u0163\u0103ri \u00een care este exportat, mai pu\u0163in \u00een \u0163ar\u0103 lui de origine\u201d, a ad\u0103ugat Damian.<\/p>\n
\nObiectivele imediate ale PRIMER sunt:<\/p>\n
\n\u2022 O revizuire a taxei clawback care s\u0103 \u0163in\u0103 cont de interesele economice ale Rom\u00e2niei \u015fi care s\u0103 ajute produc\u0103torii locali \u015fi poten\u0163iali investitori s\u0103 poat\u0103 beneficia de un mediu concuren\u0163ial corect. Aceast\u0103 \u00eenseamn\u0103 implementarea de la 1 iulie 2017 a formulei de clawback diferen\u0163iat Plx 425\/2014 care este blocat\u0103 \u00een Parlament de peste 3 ani \u015fi, \u00eencep\u00e2nd cu 2018, trecerea la taxa clawback zero pentru medicamentele generice, care nu sunt r\u0103spunz\u0103toare pentru cre\u015fterea costurilor din sistemul de s\u0103n\u0103tate.<\/p>\n
\n\u2022 Modific\u0103ri urgen\u0163e \u00een metodologia de calcul a pre\u0163urilor care s\u0103 aib\u0103 \u00een vedere excluderea prevederilor ambigue legate de patent \u015fi care s\u0103 permit\u0103 aprobarea \u015fi includerea \u00een maximum 30 de zile \u00een catalogul na\u0163ional (Canamed) a pre\u0163urilor pentru medicamentele generice;<\/p>\n
\n\u2022 Adoptarea unor facilit\u0103\u0163i fiscale pentru achizi\u0163ia de licen\u0163e de fabrica\u0163ie \u015fi echipamente de produc\u0163ie \u015fi a unor facilit\u0103\u0163i comerciale de genul celor din din Legea 150\/2016, care s\u0103 asigure prezen\u0163a unui minim de medicamente fabricate \u00een Rom\u00e2nia pe canelele comerciale, av\u00e2nd \u00een vedere c\u0103 produc\u0163ia local\u0103 poate facilita accesul f\u0103r\u0103 obstacole a pacien\u0163ilor la o gama larg\u0103 de medicamente de prima nevoie.<\/p>\n
\nPRIMER cere autorit\u0103\u0163ilor s\u0103 lanseze de urgen\u0163\u0103 consult\u0103ri cu produc\u0103torii industriali de medicamente din Rom\u00e2nia pentru identificarea m\u0103surilor care s\u0103 opreasc\u0103 criz\u0103\u00eenchiderii fabricilor de medicamente \u015fi a dispari\u0163iei medicamentelor \u015fi care s\u0103 aduc\u0103 aceast\u0103 industrie dintr-o cenu\u015fereasa a economiei \u00eentr-un factor de dezvoltare economic\u0103 accelerat\u0103.<\/p>\n
\nDin PRIMER fac parte 15 fabrici de medicamente din \u0163ar\u0103: AC HELCOR, ANTIBIOTICE, B.BRAUN, BIO-EEL SRL, BIOFARM, GEDEON-RICHTER, INFOMED FLUIDS, LABORMED-ALVOGEN, LAROPHARM, MAGISTRA CC, POLISANO PHARMACEUTICALS, SLAVIA PHARM, ZENTIVA, TERAPIA, VIM SPECTRUM.<\/p>\n","protected":false},"excerpt":{"rendered":"
Principalii produc\u0103tori de medicamente cu facilit\u0103\u0163i de produc\u0163ie \u00een Rom\u00e2nia anun\u0163\u0103 \u00eenfiin\u0163area Patronatului Produc\u0103torilor Industriali de Medicamente din Rom\u00e2nia \u2013 PRIMER – organiza\u0163ie profesional\u0103 independent\u0103 care \u00ee\u015fi propune s\u0103 conlucreze pentru c\u0103 Rom\u00e2nia s\u0103 devin\u0103 un hub european al produc\u0163iei de medicamente, spre beneficiul pacien\u0163ilor \u015fi al economiei rom\u00e2ne\u015fti. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[16199,7467,10313,9879,7442,32517,10275,32512,18509,474,18324,323,10287,11880,408,297,7147,259,541,80,98],"class_list":["post-147119","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-anunt","tag-asigurare","tag-autoritati","tag-beneficii","tag-dezvoltare","tag-economia-romaneasca","tag-fabrici","tag-facilitare","tag-independenta","tag-industrie","tag-infiintare","tag-medicamente","tag-mediu","tag-organizatie","tag-pacienti","tag-producator","tag-producatori","tag-productie","tag-propunere","tag-refuz","tag-romania"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/147119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=147119"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/147119\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=147119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=147119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=147119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}